Clinical trials for Cancer in United States

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Study ID: NCT05455320

Sponsor

Janssen Research & Development, LLC

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Study ID: NCT04421820

Sponsor

Bold Therapeutics, Inc.

Genetic Testing Decision Aid

Study ID: NCT05470920

Sponsor

Massachusetts General Hospital

Pediatric PET/MR Image Registry

Study ID: NCT03458520

Sponsor

Stanford University

Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

Study ID: NCT04690374

Sponsor

Memorial Sloan Kettering Cancer Center

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

Study ID: NCT03088020

Sponsor

Debra orphan-Mayer

Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery

Study ID: NCT05898074

Sponsor

Indiana University

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Study ID: NCT06253520

Sponsor

National Cancer Institute (NCI)

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Study ID: NCT06625320

Sponsor

Revolution Medicines, Inc.

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Study ID: NCT06117774

Sponsor

Amgen